Electra Therapeutics Announces $84 Million Series B Financing And Unveils Its Novel Sirp‑Targeted Therapies For Immunological Diseases And Cancer
Amount Raised
$84 Million
Round Type
Series B
Description
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies that target signal regulatory proteins (SIRP), announced today a $84 million Series B financing co-led by Westlake Village BioPartners and OrbiMed. Other participating investors include Redmile Group, Cormorant Asset Management, Cowen Healthcare Investments, RA Capital, and New Leaf Venture Partners. Electra was previously funded by its parent company, Star Therapeutics.
Who else raised in Sustainability and Science And Engineering around the same time
Companies in the same sectors as Electra Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Co-Diagnostics, Inc. raised $47M on January 14, 2022.
- 2seventy bio raised $170M on March 31, 2022.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
- Geneos Therapeutics raised $17M on March 28, 2022.
- Geneos Therapeutics raised $17M (Series A) on March 24, 2022.
Who to call at Electra Therapeutics, and when
A new round usually means Electra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Electra Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Electra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansElectra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.